Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients

Condition:   Diabetes Mellitus, Type II Interventions:   Drug: Voglibose + Metformin;   Drug: Glibenclamide + Metformin Sponsors:   University of Zambia;   University Teaching Hospital, Lusaka, Zambia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials